NSW Minister for Health and Medical Research, The Honourable Brad Hazzard MP, visited The George Institute, China on 7 December with a health and medical delegation led by the Minister in China as part of the NSW-Guangdong Joint Economic Meeting (JEM) on 5 December. The Secretary of NSW Health, Elizabeth Koff, and Special Envoy to China, Dr Jim Harrowell AM also attended.
Jiachao Ji is a biostatistician at The George Institute, China, and is currently responsible for ORBIT、DOSA2 and Beyond Ⅶ projects. Today, let’s listen to his profile story and step into his inner world.
The George Institute for Global Health today received a landmark investment of $24 million from the Australian Government to undertake research to prevent and treat cardiometabolic diseases, which affect seven million Australians and hundreds of millions globally.
To celebrate 10 years of The George Institute for Global Health being established in China, the 2017 John Yu Oration celebratory event was hosted by The China-Australia Chamber of Commerce (AustCham) in Beijing on 3 November. Over 130 distinguished guests, including policymakers, members of the health and business sectors, and diplomats, academics and scientists participated.
On 3 November 2017, on the 10th anniversary of the establishment of The George Institute, China (GI China), a symposium entitled ‘Innovations in Research and Health Care’ was successfully held in Beijing, organized by Peking University Health Science Center (PUHSC) and UNSW Sydney, with the technical support of GI China.
The George Institute (GI) for Global Health China has been invited by UNSW Sydney (the University of New South Wales) to participate in a mini-roadshow on 1 November, organized as part of the Torch High Technology Development Centre of the Chinese Ministry of Science and Technology, to discuss innovations in digital health to improve the health of older people.
In October 2017, INTERACT3, the third in a series of INTERACT studies, has been launched. This time called the INTEnsive care bundle with blood pressure reduction in Acute Cerebral haemorrhage Trial, it was successfully launched across a network of more than 80 hospitals in China.